At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 93 enrolled
Drug / intervention
Leukocyte-rich platelet-rich plasma +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison Efficacy of Intraarticular Knee Injection in Knee Osteoarthritis With Leukocyte-rich and Leukocyte-poor Platelet-rich Plasma
Queen Savang Vadhana Memorial Hospital, Thailand·interventional·Posted Feb 21, 2023·Updated Feb 21, 2023
In Brief
A Phase 3 clinical trial evaluating Leukocyte-rich platelet-rich plasma, Leukocyte-poor platelet-rich plasma, and 1 other intervention for Osteo Arthritis Knee. Completed, enrolled 93 participants across 1 site.
Detailed Summary
To compare the efficacy of intraarticular knee injection between leukocyte-rich and leukocyte-poor platelet-rich plasma in knee osteoarthritis treatment
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteo Arthritis Knee
CountriesThailand
Collaborators--
Timeline
Phase 3CompletedFinished
202120222023202420252026
Enrollment StartAug 2020
Primary CompletionSep 2022
Study CompletionOct 2022
First PostedFeb 2023
TodayJul 2026
First PostedFeb 21, 2023
Enrollment StartAug 3, 2020
Primary CompletionSep 1, 2022
Study CompletionOct 1, 2022
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 3.4 years ago
Interventions
Leukocyte-rich platelet-rich plasmadrug
Intra-articular knee injection
Leukocyte-poor platelet-rich plasmadrug
Intra-articular knee injection
Corticosteroiddrug
Intra-articular knee injection